Physician profile
Simon B Rayhanabad
NPI 1710910047
$27,974.91
in general payments reported to CMS, 2019-2025
41 companies · $8,193 in 2025
The $8,193 reported for 2025 was more than what 89% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,727 · 2020: $4,878 · 2021: $4,385 · 2022: $604 · 2023: $863 · 2024: $326 · 2025: $8,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,500 · Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,500.00 |
| Food and Beverage | $1,881.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,521.40 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Intuitive Surgical, INC. | $6,269.00 | 2019-2024 | |
| Endologix LLC | $3,081.35 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Artegraft INC. | $2,855.00 | 2019 | |
| Silk Road Medical, INC. | $2,039.35 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cardiovascular Systems INC. | $1,903.18 | 2019 | |
| Davol INC. | $471.05 | 2020-2024 | Venclose Maven Catheter |
| Smith+Nephew, INC. | $371.79 | 2019-2025 | Renasys Go V2 Home, Pico 7, Pico 14 |
| Janssen Pharmaceuticals, INC | $357.50 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $345.55 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Livanova USA, INC. | $328.23 | 2019-2024 | Vns Therapy Symmetry Model 8103 Generator, Vns Therapy Sentiva Model 1000 Generator |
| Integra Lifesciences Corporation | $295.40 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $253.06 | 2022-2025 | Endurant Iis, In.Pact Av |
| Bolton Medical INC | $248.04 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Biotissue Holdings INC. | $234.44 | 2021-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $168.29 | 2020-2025 | Perclot, Floseal |
| Lemaitre Vascular, INC. | $159.95 | 2019-2023 | Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $149.25 | 2019 | |
| Cook Medical LLC | $113.78 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $100.06 | 2021-2022 | |
| Cvrx, INC. | $89.46 | 2022-2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $82.11 | 2019-2022 | |
| Inspiremd LTD | $77.47 | 2025 | Cguard Prime Carotid Stent System |
| Conmed Corporation | $64.95 | 2023 | Airseal |
| Boston Scientific Corporation | $51.45 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| Aroa Biosurgery Incorporated | $40.78 | 2022 | |
| Tei Biosciences INC | $37.23 | 2019 | |
| Covidien LP | $33.27 | 2019 | |
| Organogenesis INC. | $33.17 | 2024 | |
| Olympus America INC. | $25.76 | 2021 | |
| Cardiva Medical, INC. | $22.39 | 2021 | |
| Bsn Medical INC | $19.34 | 2025 | |
| Checkpoint Surgical, INC | $17.53 | 2019 | |
| Biocompatibles, INC. | $17.22 | 2019 | |
| Ethicon US, LLC | $17.18 | 2020 | |
| Philips North America LLC | $15.38 | 2021 | |
| Tactile Systems Technology INC | $14.27 | 2019 | |
| Kci USA, INC. | $13.83 | 2023 | Prevena, V.A.C.Instill |
| Mimedx Group, INC. | $13.62 | 2025 | |
| Trevena, INC. | $11.68 | 2021 | |
| Acell, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Rayhanabad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.